What is the optimal dose and schedule of treatment of endometrial hyperplasia using the various progestins? Is the use of depot medroxyprogesterone a good option for treatment? Patients with ...

Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

This page lists all known medications that could potentially lead to 'Endometrial hyperplasia' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Although it might seem reasonable to pronounce women cured after their endometrial hyperplasia regresses from hormonal treatment, researchers caution that long-term monitoring for relapse and cancer ...

Please provide your email address to receive an email when new articles are posted on . Conjugated estrogen/bazedoxifene users had higher endometrial cancer and endometrial hyperplasia rates vs.

Researchers studied the prevalence of proliferative endometrial disorders in women with adenomyosis and evaluated the association between adenomyosis and each lesion type.

Women with atypical endometrial hyperplasia have an increased risk of developing cancer Researchers from the University of Edinburgh have revealed that improved patient care is needed to reduce cancer ...

The Kaiser Permanente Center for Health Research (KPCHR) is the research arm of the Kaiser Permanente Northwest (KPNW) pre-paid health plan (Wagner et al, 2005). Since the early 1940s, the KPNW has ...

Several studies have investigated the mechanisms involved in progestin resistance. Decreased availability of progestin receptors before treatment or alterations in progestin receptor regulatory ...

Endometrial hyperplasia (EH) is a condition in which the uterine lining is thicker than normal. It may have many causes, but the most important association is with endometrial malignancy. For this ...

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2 We conducted a case ...

Endometrial hyperplasia describes a condition in which the lining of the uterus, called the endometrium, becomes too thick. The condition itself is not cancerous; however, it sometimes can lead to ...